Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 5/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22502736 | 0.87 | PRMT5 (0.39) | MBOAT4PRMT5KCNH2HRH3 | |
| SCHEMBL17825442 | 0.81 | DDB1 (0.42) | MBOAT4 | |
| SCHEMBL24323890 | 0.81 | PRMT5 (0.41) | MBOAT4PRMT5KCNH2HRH3 | |
| SCHEMBL29515354 | 0.81 | PRMT5 (0.41) | MBOAT4PRMT5KCNH2HRH3 | |
| Hydrochloric Acid SCHEMBL17825460 | 0.80 | DDB1 (0.41) | MBOAT4 | |
| SCHEMBL23114391 | 0.78 | PRMT5 (0.38) | MBOAT4PRMT5 | |
| SCHEMBL22384243 | 0.76 | DRD2 (0.36) | PRMT5HRH3 | |
| SCHEMBL19088565 | 0.75 | TNKS (0.43) | KCNH2HRH3 | |
| SCHEMBL17675631 | 0.75 | PRMT5 (0.40) | MBOAT4PRMT5 | |
| SCHEMBL15805581 | 0.74 | MBOAT4 (0.43) | MBOAT4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | MBOAT4 3796/4885PRMT5 998/4885KCNH2 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.